SLC6A4, solute carrier family 6 member 4, 6532

N. diseases: 440; N. variants: 28
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003862
Disease: Arthralgia
Arthralgia
0.010 GeneticVariation phenotype BEFREE In 5HTT, the rs1042173 was associated with painful TMD (arthralgia and myofascial pain) (OR<sub>c</sub>  = 1.97; CI 95%: 1.02-3.77; P = 0.04). 30811655 2019
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.010 AlteredExpression phenotype BEFREE Although there was no significant change in TPH1 mRNA, the mRNA of TPH2 and SLC6A4 was significantly decreased in FGR placentae (p < 0.05), while 5-HT receptor mRNA was significantly increased in FGR compared with control (p < 0.01). 31176514 2019
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.010 GeneticVariation disease BEFREE We found that the association between SLE load and MS depression severity was stronger among those with one or two copies of the short allele of the 5-HTTLPR. 29683385 2019
CUI: C0039494
Disease: Temporomandibular Joint Disorders
Temporomandibular Joint Disorders
0.010 GeneticVariation group BEFREE In 5HTT, the rs1042173 was associated with painful TMD (arthralgia and myofascial pain) (OR<sub>c</sub>  = 1.97; CI 95%: 1.02-3.77; P = 0.04). 30811655 2019
CUI: C0086168
Disease: Dissociation
Dissociation
0.010 GeneticVariation disease BEFREE For boys, higher ASD traits were associated with the 5-HTTLPR LL genotype in combination with either a negative maternal appraisal of the flood, or high levels of maternal composite subjective stress, PSTD-like or peritraumatic dissociation symptoms. 30394245 2019
CUI: C0152459
Disease: Linear atrophy
Linear atrophy
0.010 Biomarker disease BEFREE Therefore, we combined immunohistochemistry, high resolution confocal imaging, and 3D-reconstruction techniques to map and quantify the distribution of VGLUT3 immunoreactive boutons within 5-HT vs. SERT-positive axons in various regions of the mouse forebrain, including the prefrontal cortex, nucleus accumbens core and shell, bed nucleus of the stria terminalis, dorsal striatum, lateral septum, basolateral and central amygdala, and hippocampus. 31133811 2019
CUI: C0162429
Disease: Malnutrition
Malnutrition
0.010 GeneticVariation disease BEFREE The opposite effects of 5-HTTLPR polymorphism on global network characteristics in the two groups suggest an interaction of the short allele and malnutrition in modulating brain network properties. 31680805 2019
CUI: C0553642
Disease: Soft tissue rheumatism
Soft tissue rheumatism
0.010 GeneticVariation disease BEFREE In 5HTT, the rs1042173 was associated with painful TMD (arthralgia and myofascial pain) (OR<sub>c</sub>  = 1.97; CI 95%: 1.02-3.77; P = 0.04). 30811655 2019
CUI: C0748073
Disease: psychosocial stressor
psychosocial stressor
0.010 Biomarker disease BEFREE The current candidate gene and environment interaction (cGxE) study examined whether the effects of an experimentally manipulated psychosocial stressor on self-reported drinking urge and implicit attentional bias for alcohol cues differ as a function of a cumulative genetic score of 5-HTTLPR, MAO-A, DRD4, DAT1 and DRD2 genotypes. 30192917 2019
CUI: C0752347
Disease: Lewy Body Disease
Lewy Body Disease
0.010 Biomarker disease BEFREE We aimed to study degeneration of terminals with dopamine and serotonin transporter (DAT and SERT, respectively) in patients with early-stage PD and DLB relative to healthy controls, using <sup>123</sup>I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (<sup>123</sup>I-FP-CIT) single photon emission computed tomography (SPECT). 30884365 2019
CUI: C0948008
Disease: Ischemic stroke
Ischemic stroke
0.010 GeneticVariation disease BEFREE SERT gene polymorphisms in 270 non-depressed first-ever acute ischemic stroke patients randomized to citalopram, n = 130, or placebo, n = 140, were investigated. 30844812 2019
CUI: C0001622
Disease: Adrenal Gland Hyperfunction
Adrenal Gland Hyperfunction
0.010 AlteredExpression phenotype BEFREE The following molecular candidates can help to differentiate PSD patients from non-depressed stroke subjects: decreased serum BDNF concentrations; increased early markers of inflammation (high-sensitivity C-reactive protein, ferritin, neopterin, and glutamate), serum pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-18, IFN-γ), as well as pro-inflammatory/anti-inflammatory ratios (TNF-α/IL-10, IL-1β/IL-10, IL-6/IL-10, IL-18/IL-10, IFN-γ/IL-10); lowered complement expression; decreased serum vitamin D levels; hypercortisolemia and blunted cortisol awakening response; S/S 5-HTTLPR, STin2 9/12, and 12/12 genotypes of the serotonin transporter gene SLC6A4, 5-HTR2a 1438 A/A, and BDNF met/met genotypes; higher SLC6A4 promoter and BDNF promoter methylation status. 30061860 2018
CUI: C0004930
Disease: Behavior Disorders
Behavior Disorders
0.010 Biomarker group BEFREE The human monoamine transporters (hMATs) primary including hSERT, hNET and hDAT are important targets for the treatment of depression and other behavioral disorders with more than availability of 30 approved drugs. 30306851 2018
CUI: C0007113
Disease: Rectal Carcinoma
Rectal Carcinoma
0.010 GeneticVariation disease BEFREE The SERT gene promoter SNP rs25531 was associated with the CRF in patients with colon and rectal cancer and the G genotype was an independent risk factor for CRF among individuals with colon and rectal cancer in the study. 29551185 2018
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.010 GeneticVariation disease BEFREE STin2 VNTR polymorphism of SLC6A4 gene may contribute to CD pathogenesis. 30394015 2018
CUI: C0017650
Disease: Globus Hystericus
Globus Hystericus
0.010 GeneticVariation phenotype BEFREE We investigated the association between the SLC6A4 polymorphism and globus pharyngeus and its response to treatment with antidepressants. 29310115 2018
CUI: C0018553
Disease: Hamartoma Syndrome, Multiple
Hamartoma Syndrome, Multiple
0.010 GeneticVariation disease BEFREE To analyze the distribution of SLC6A4 gene polymorphisms in Crohn's disease (CD) patients and their association with the disease. 30394015 2018
CUI: C0024586
Disease: Malignant Carcinoid Syndrome
Malignant Carcinoid Syndrome
0.010 Biomarker disease BEFREE SERT inhibition by tramadol, tapentadol, methadone, dextromethorphan and pethidine may contribute to the serotonin syndrome. 29210063 2018
CUI: C0033770
Disease: Prune Belly Syndrome
Prune Belly Syndrome
0.010 AlteredExpression disease BEFREE At the first week, SERT protein levels were basically comparable in rats treated with undiluted LGG-s, double-diluted LGG-s, and triple-diluted LGG-s, which were higher than those in the control group and PBS-treated PI-IBS group. 29391756 2018
CUI: C0233461
Disease: Emotional impulsivity
Emotional impulsivity
0.010 GeneticVariation disease BEFREE Furthermore, the link of s allele of 5-HTTLPR to emotional impulsivity was mediated by depressive symptoms, particularly perceptions of social rejection. 29090386 2018
CUI: C0235969
Disease: Disorder of ejaculation
Disorder of ejaculation
0.010 GeneticVariation disease BEFREE The innovative study design elaborates that androgen receptor trinucleotide repeats and 5-HTTLPR genotypes have combinatorial impact on hormonal milieu and sexual function regarding evidence-based lifelong premature ejaculatory dysfunction patients. 30019487 2018
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
0.010 Biomarker group BEFREE MDMA acts at dopamine (DA) transporter (DAT) and serotonin (5-HT) transporter (SERT) and is known to induce damage of dopamine and serotonin neurons.MDMA is often ingested with caffeine. 29134560 2018
CUI: C0239849
Disease: Harlequin Fetus
Harlequin Fetus
0.010 Biomarker disease BEFREE In two large community samples, the moderating role of 5-HTTLPR was examined related to more hyperactivity-impulsivity symptoms (HI symptoms) predicted by more peer problems. 28295205 2018
CUI: C1720830
Disease: Painful Bladder Syndrome
Painful Bladder Syndrome
0.010 AlteredExpression disease BEFREE At the first week, SERT protein levels were basically comparable in rats treated with undiluted LGG-s, double-diluted LGG-s, and triple-diluted LGG-s, which were higher than those in the control group and PBS-treated PI-IBS group. 29391756 2018
CUI: C0021831
Disease: Intestinal Diseases
Intestinal Diseases
0.010 Biomarker group BEFREE Alterations in 5-HT transmission have been linked to pathological symptoms in both intestinal and psychiatric disorders and selective 5-HT transporter (5-HTT) inhibitors, affecting the 5-HT system by blocking the 5-HT transporter (5-HTT) have been successfully used to treat CNS- and intestinal disorders. 28824378 2017